Pamela Vida

Pamela Vida is an experienced professional in market access and oncology strategy, currently serving as Senior Director of Market Access Oncology Strategy, Pricing, and Analytics at Gilead Sciences since July 2020. Over an extensive career spanning more than two decades, Pamela has held multiple senior roles including Senior Director of Market Access Strategy for Oncology & COVID-19 and Managed Markets Oncology Strategy & Reimbursement at Gilead Sciences. Prior experience includes leadership positions at Aimmune Therapeutics, Genentech, Edge Dynamics, and Eli Lilly & Company. Pamela holds a Bachelor of Science in Finance from Villanova University, obtained in 2002.